New Formulation of FDA-Approved Drug Shows Encouraging Results for Treating a Common Itch Condition in Phase 2 Clinical Trial.

Press/Media

Period9 Feb 2023

Media coverage

1

Media coverage

  • TitleNew Formulation of FDA-Approved Drug Shows Encouraging Results for Treating a Common Itch Condition in Phase 2 Clinical Trial.
    Media name/outletPRWeb Newswire
    Country/TerritoryUnited States
    Date9/02/23
    PersonsBrian Kim
View all 1
View less